Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Brodows

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Metabolism: Clinical and Experimental|February 1, 1976
Glucagon responses to hypoglycemia in adrenalectomized manJ W Ensinck, R M Walter, J P Palmer, et al.
Diabetes Care|September 8, 2000
Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study GroupE J Bastyr, C A Stuart, R G Brodows, et al.
Diabetes Care|November 5, 1998
A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetesR B Goldberg, D Einhorn, C P Lucas, et al.
Clinical Chemistry|October 1, 1983
Free thyroxin by radioimmunoassay: evaluation of a new direct method involving a radiolabeled thyroxin analogN P Kubasik, P A Lundberg, R G Brodows, et al.
Diabetes, Obesity & Metabolism|June 17, 2006
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitusR E Ratner, D Maggs, L L Nielsen, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Metabolism: Clinical and Experimental|February 1, 1976
Glucagon responses to hypoglycemia in adrenalectomized manJ W Ensinck, R M Walter, J P Palmer, et al.
Diabetes Care|September 8, 2000
Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study GroupE J Bastyr, C A Stuart, R G Brodows, et al.
Diabetes Care|November 5, 1998
A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetesR B Goldberg, D Einhorn, C P Lucas, et al.
Clinical Chemistry|October 1, 1983
Free thyroxin by radioimmunoassay: evaluation of a new direct method involving a radiolabeled thyroxin analogN P Kubasik, P A Lundberg, R G Brodows, et al.
Diabetes, Obesity & Metabolism|June 17, 2006
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitusR E Ratner, D Maggs, L L Nielsen, et al.
Pageof 3